Results
40
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
40 companies
Bod Science
Market Cap: AU$4.3m
Bod Science Limited operates as a cannabis focused drug development and product innovation company in Australia, the United Kingdom, the European Union, and the United States.
BOD
AU$0.024
7D
0%
1Y
-65.2%
Patrys
Market Cap: AU$4.1m
Develops and commercializes antibody technologies for the treatment of cancer in Australia.
PAB
AU$0.002
7D
0%
1Y
-77.8%
AdAlta
Market Cap: AU$3.9m
A clinical stage biotechnology company, discovers and develops protein and cell-based therapeutics by its i-body platform in Australia.
1AD
AU$0.006
7D
-14.3%
1Y
-80.6%
Biotron
Market Cap: AU$2.7m
A biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia.
BIT
AU$0.003
7D
-14.3%
1Y
-96.1%